Ignite Creation Date:
2024-05-06 @ 9:23 AM
Last Modification Date:
2024-10-26 @ 12:14 PM
Study NCT ID:
NCT02974725
Status:
TERMINATED
Last Update Posted:
2024-05-17
First Post:
2016-11-23
Brief Title:
A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-24
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-24
Completion Date Type:
ACTUAL
First Submit Date:
2016-11-23
First Submit QC Date:
November 23 2016
Study First Post Date:
2016-11-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-15
Last Update Post Date:
2024-05-17
Last Update Post Date Type:
ACTUAL